chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 months after initial vaccine (had minor rash immediately after)...Reported to ER at a local Hospital  Diagnosed with idiopathic healthy heart ventricular tachycardia. Inpatient 5 days, multiple meds and tests performed. Scheduled for cardiac ablation 2/14/22
Here are the symptoms I am having:  ? New Headache started afternoon of 5/23 and continues still at present ? Worsening Tinnitus started 5/23 evening and continues still at present. For background, I experienced new onset Tinnitus with my first does of Pfizer COVID Vaccination. At first it was severe and over the months lessened into a mild background bilateral tinnitus. This was reported as a VAERS to the VAERS System by the previous our Nurse, Infection Control Nurse, and Dr. Infectious Disease Physician.  ? New Blurred Vision stared 7:30pm 5/24/22 and continues today.
Rash arms, legs, hands, torso, face began 10/21/03. Tx: Rx Steripred DS Dose pack for 12 days, Rx: Benadryl.
Pt developed passive swelling of the left triceps, 13.0cm vertically and diameter from 15.4-18.0cm with mild erythema. No pain or bother to the child. On 8/21/01, pt fully recovered, per mom.
2NOV93 pt recvd vax & 3NOV93 felt cold coming on, sl sore throat, & malaise; 4NOV93 tenderness under arm pit; all sx cont until 8NOV93; @ which time all better;
Mom stated 1 and 1/2 hours after receiving the vaccine (6 p.m.) client had joint pain, severe headache and felt "very, very weak". At 9 p.m. her mom stated that patient told her she "couldn't see". That lasted 10 secs. patient also vomited x2. Mom took her to the E.R. around 9:15 p.m. Patient had 1 more episode of not being able to see for about 10 secs. Mom stated her B/P was 81/43. She was given 2 liters of fluid I.V. in E.R. Eventually she recovered and was sent home around 2 a.m.
Passed out; Hit her head 3 times; White Blood Cell Increased; Bloody nose that would not stop; Felt nauseated; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) and HEAD INJURY (Hit her head 3 times) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Diabetes since an unknown date. Concomitant products included POTASSIUM, VITAMIN D3, TRAMADOL, LEVOTHYROXINE, METOLAZONE, SPIRONOLACTONE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion hospitalization), HEAD INJURY (Hit her head 3 times) (seriousness criterion hospitalization), EPISTAXIS (Bloody nose that would not stop) and NAUSEA (Felt nauseated). On an unknown date, the patient experienced WHITE BLOOD CELL COUNT INCREASED (White Blood Cell Increased). The patient was hospitalized from 17-Mar-2021 to 24-Mar-2021 due to HEAD INJURY and LOSS OF CONSCIOUSNESS. On 17-Mar-2021, LOSS OF CONSCIOUSNESS (Passed out), HEAD INJURY (Hit her head 3 times), EPISTAXIS (Bloody nose that would not stop) and NAUSEA (Felt nauseated) had resolved. At the time of the report, WHITE BLOOD CELL COUNT INCREASED (White Blood Cell Increased) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.  After hospitalization patient was started with Januvia, Pregabalin, Potassium chloride, Torsemibe, Metoprolol, Levemir insulin  Company comment:Based on the current available information and the temporal association between the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product and the start date of the events a causal relationship cannot be excluded.
PNEUMONIA; SUSPECTED CLINICAL VACCINATION FAILURE; GOT COVID AFTER VACCINATION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex and unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient previously received covid-19 vaccine from unspecified manufacturer (form of admin, route of admin, and batch number were not reported), dose was not reported (dose number in series 1), for prophylactic vaccination. No adverse events were reported following administration of covid-19 vaccine (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported for prophylactic vaccination (dose number in series 2). The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced pneumonia, suspected clinical vaccination failure, and got covid after vaccination (captured as: suspected Covid-19 infection) (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from got covid after vaccination (captured: suspected Covid- 19 infection) and the outcome for suspected clinical vaccination failure and pneumonia was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter was linked to 20211212673 and 20211212261. This report was associated with regulatory authority: 90000206895.; Sender's Comments: V0: 20211223580-covid-19 vaccine ad26.cov2.s-pneumonia, got covid after vaccination. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  20211223580-covid-19 vaccine ad26.cov2.s-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Large reddened area around vaccine site on right arm radiating down upper arm and around posteriorly.  Patient complained of chills evening of vaccine date.
Fever up to 102 degrees pain at site headache chills muscle pain nausea felt unwell  Took Tylenol for fever and aches
ADULT DOSE PFIZER BIIONTECH VACCINE WAS GIVEN TO A PEDIATRIC PATIENT LESS THAN 12 YEARS. NO SYMPTOM AT THIS TIME.
Initial case was retrieved from the scientific literature on 08 June 2011. "The National Vaccine Injury Compensation Program (VICP) was established in 1986 in response to vaccine safety concerns. A unique feature is a table of compensable injuries, the Vaccine Injury Table (VIT). Anaphylaxis is a listed adverse event with an interval of 0 to 4 hours for vaccines containing tetanus toxoid (tetanus, diphtheria, and pertussis vaccine and tetanus-diphtheria [Td] vaccine), pertussis (diphtheria, pertussis, and tetanus [DPT] and diphtheria and tetanus toxoids with acellular pertussis [DTaP] vaccines), measles, mumps, and rubella (MMR), inactivated polio virus (IPV), and hepatitis B virus (HBV). In 2009, the VICP charged the Institute of Medicine with the task of completing a comprehensive review of the medical literature regarding adverse events related to vaccines so that the VIT could be updated. Concurrent with the Institute of Medicine's review, we undertook a systemic analysis of the VICP's anaphylaxis case experience. The VICP administrative database was queried for all cases submitted to the VICP alleging "anaphylaxis or anaphylactic shock" for the 10-year period from January 1, 2000, through December 31. 2009." The patient captured in this case was one of 8 noted in the above reference that experienced anaphylaxis after vaccination. A pediatric female patient (age not reported) with no medical history, received the following vaccination on an unknown date with unknown manufacturers and unknown lot numbers: an injection (route and site not reported) of  DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE, an injection (route and site not reported) of POLIOMYELITIS VACCINE INACTIVATED, and an injection (route and site not reported) of MMR. On an unknown date within minutes to hour after receiving the vaccines, the patient developed anaphylaxis with symptoms of abdominal pain, hives, decreased consciousness, and hypotension. The patient was treated with epinephrine, and diphenhydramine. The outcome was reported as recovery to previous immunization state (PIS). The reporter in this case is the same as cases: 2011-03324, 2011-03327, 2011-03328, 2011-03330, 2011-03331, 2011-03332, and 2011-03333. Documents held by sender: None.
headache, chills, hurts to move, vomiting, diahrea, rash and itchy
Patient came in on 10/15/20 and reported localized swelling that traveled to elbow.  She also had redness around injection sight.  She did not use anything to treat it.  The swelling decreased over time and was cleared up in 48 hours.
Experiencing shortness of breath and chest pains. No medications have been taken, no appointments made with PCP at this time.
An entire moderna multi dose vile 2.5ml/250mcg was given in left deltoid Mother who is a pediatric nurse discovered the error
swelling and rash at site shortly after administration that lasted 2-3 days then developed a knot in upper inner left arm that radiates pain down left arm and has lasted 2-3 weeks
It felt like I was having a heart attack. 3 days after vaccination, I was climbing stairs and I started have a bit of chest pain and tightening in my chest; similar to a heart attack. I felt weak but as soon as I stopped movement, it went away. But every time I started movement, I could feel the pain again.
She got her vaccine, had no problems, then later in the evening after dinner she was shaking, hot and cold and was very weak.  She was feeling very bad.  She could not stand, had to lie down and the only time she got up that night was to go to the bathroom and was still shaking.  That night one tooth was very sensitive on the back side on the left.  On Saturday she noticed the lymph nodes under the left arm were swollen and sensitive if she pressed her arm down to her body it bothered her.  The swelling lasted until today, 10/11/22, which it went down a little bit, but is mostly normal now.  The sensitivity to the teeth also disappeared by Sunday.  These symptoms were all on her left side.    She had a flu shot the Monday before the booster and she had no reaction to it.  The arm where they gave the shot has no reaction other than just soreness of the arms.  The other boosters she had her arm was sore for a day or so but no other reactions like this.  She still has weakness, but is feeling so much better than she did.
Within five minutes of receiving the vaccine the patient began to experience symptoms. Symptoms of profuse sweating, tingling in the arms, and legs as well as nausea. 911 was phoned, upon arrival the EMS agent interviewed pt and walked with pt to the ambulance for health readings such as blood pressure. Ten minutes later the patient left in stable condition.
After the 3 vaccines, patient started to faint, a pair of glasses dropped to the floor, weak, skin pale, sweating, checked BP 90/55 P50, patient stated he felt weird, after 3 minutes patient started to be back, verbalized " a little better" but " super tired". Patient gradually recovered after 15 minutes observation, rechecked BP 95/65, P 70.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 75 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE; ATORVASTATIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment included Paxlovid (start date 22Sep2022, stop date 26Sep2022). Known allergies: None known.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 24-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 01-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was given for the patient. It was reported that the vaccines were stored in freezer, were taken out one to two vials and were placed in fridge each day as needed.
PUI reported he went to work and began to feel bad, went to the ER ad tested positive for COVID. PUI informed he had several stints in his heart and thought he was having issues. . PUI stated he was a patient at from 8/11-8/14/21.
Received H1N1 nasal spray on 10/29/09. Dev. high fever, cough, rash, welling of eyes, vomiting on 10/30/009 - Seen in office on 11/3/09. Temp 102.4. No distress. Scattered erythematous papular rash on trunk, sl. redness around the eye. Rest of exam was WNL.
Severe chills and rigors woke me from sleep at 0300 lasted approximately 1 hour. Took 500mg Tylenol at 0315.  Woke up at 0430 with severe nausea. No treatment. went back to sleep. Extreme fatigue the day after the injection. Rested and hydrated. Day 2 post injection, mild body aches and mild fatigue.
Approximately 2 weeks post vas pt developed a maculopapular erythematous rash on his face, chest, neck and back, as well as a sore throat and general malaise. Pt was afebrile and was treated with Benadryl.
red spots/patches all over body with itching; red spots/patches all over body with itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red spots/patches all over body with itching) and PRURITUS (red spots/patches all over body with itching) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ERYTHEMA (red spots/patches all over body with itching). On an unknown date, the patient experienced PRURITUS (red spots/patches all over body with itching). At the time of the report, ERYTHEMA (red spots/patches all over body with itching) and PRURITUS (red spots/patches all over body with itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
This is a spontaneous report received from contactable other HCP/consumer or other non-HCP. A 46-year-old male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 46, single dose, for COVID-19 immunisation. The patient's relevant medical history not reported. Concomitant medication included Xeljanz XR, start date: Sep 1, 2020. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), single dose, for COVID-19 immunisation. The patient experienced malaise (the 2nd dose of COVID-19 vaccine made her feel terrible), with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Starting around 12 hours after getting my second shot I started experiencing nausea along with loss of taste. The next morning (1/26) I lost all taste and had no smell. The nausea has continued as well.
Vaccine administered 10/2/2017-Patient came to office for evaluation 10/4/2017. Redness, swelling and tenderness of the ventral aspect left upper arm from 2cm above the acromion process to just below the deltoid. No open area; no drainage, area approx 10cm diameter.
NEEDLE & SYRINGE MALFUNCTIONED FELL APART AND THE DOSE WAS NOT ADMINISTERED; BUMP ON HER ARM; MEDICATION ERROR; This spontaneous report received from a pharmacist concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 05-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 05-MAY-2021, the subject experienced needle & syringe malfunctioned fell apart and the dose was not administered. On 05-MAY-2021, the subject experienced bump on her arm. On MAY-2021, the subject experienced medication error. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bump on her arm, medication error and needle & syringe malfunctioned fell apart and the dose was not administered was not reported. This report was non-serious.
I started coughing, tightness in chest, sore throat, and nasal congestion. The symptoms started to get worse. I had slight fever, body aches, headaches, chills, and oxygen level got down to 93. I tested positive at home and at the doctor's office for COVID-19. My doctor prescribed me PAXLOVID on 10/19/2022. I also was taking ROBITUSSIN CF and NYQUIL cold and flu. I tested negative on the 24th. I still have coughing and head congestion.
Pt said night of vaccine she got dizzy and blurry vision. She went to ER she still feels dizzy and one eye is blurry. Going to see neurology.
MD rpt pt recv varivax in 12/97 & in 4/98 pt exp herpes zoster rash, otitis media, & low grade fever. treated w/amoxicillin. recovered  from rash but left hyperpigmented scar which healed
No adverse event; Administerd expired vaccine/ Patient received the 6th dose (2nd bivalent) as an expired dose on 16Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administerd expired vaccine/ Patient received the 6th dose (2nd bivalent) as an expired dose on 16Jun2023) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7171B) for COVID-19 prophylaxis.     Patient did not report any relevant medical history, conditions, allergy, concomitant diseases and risk factor (including any previous COVID-19 diagnosis).     On 16-Jun-2023, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 16-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administerd expired vaccine/ Patient received the 6th dose (2nd bivalent) as an expired dose on 16Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administerd expired vaccine/ Patient received the 6th dose (2nd bivalent) as an expired dose on 16Jun2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administerd expired vaccine/ Patient received the 6th dose (2nd bivalent) as an expired dose on 16Jun2023).    No concomitant drug was reported.  Reporter wanted to know should the patient received another vaccine, or can they accept the dose given as a proper dose. Reporter did not provide previous dose administered.  No treatment drug was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2023: Live follow-up received: Additional reporter and suspect product information was updated.
Fever to 104.5 F (oral) whole body vesicular rash. Developed 12 days after Varicella, MMR and Pneumococcal vaccine was administered on 4/18/08
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 14-NOV-2013 the patient was vaccinated with MMR II (lot # 1251AA and expiry date 01-AUG-2013), (dose 0.5 milliliters), subcutaneous. Expired dose of MMR II was administered to the patient on that day. No adverse effects were reported. Additional information has been requested.
Slight soreness in  left arm where the shot was administered; This is a spontaneous report from a non-contactable consumer, patient. A 32- year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch number: EN6208) via unspecified route of administration in the left arm on 16Mar2021 at 11:45 pm as a first dose for COVID-19 immunisation (Age at vaccination: 32 Years). Medical history and concomitant medications were not provided. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 patient had experienced Slight soreness in his left arm where the shot was administered. The patient did not receive any treatment for the event. The clinical outcome of event was recovering at time of reporting. No follow-up attempts are needed. No further information is expected.